This is not the official US FDA website.

In an effort to protect against the rising occurrence of potentially unsafe counterfeit drugs reaching consumers, the FDA is announcing a new initiative to more aggressively protect American consumers from the risks posed by counterfeit drugs.

As part of this effort, FDA has created a new internal task force that will develop recommendations for steps FDA, other government agencies, and the private sector can take to minimize the risks to the public from counterfeit drugs getting into the supply chain.

In addition, counterfeiting in recent years has shifted increasingly into "finished" pharmaceuticals (the final product taken by the patient) as opposed to counterfeiting of "bulk" drug ingredients in the past.

As drug manufacturing and the distribution system have become more complex, there are increased opportunities to introduce more legitimate appearing products into the drug supply in the U.S., and the challenge of protecting against unsafe counterfeit drugs has become more difficult.

Counterfeit Product Alerts: (8) view_all

Contact the Company:

Accreditation:

Jobs at US Food & Drug Administration: